Related references
Note: Only part of the references are listed.Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression
Kristen M. Turner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
DDB2 Suppresses Tumorigenicity by Limiting the Cancer Stem Cell Population in Ovarian Cancer
Chunhua Han et al.
MOLECULAR CANCER RESEARCH (2014)
Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies
Sameer Agnihotri et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
Loss of Neil3, the major DNA glycosylase activity for removal of hydantoins in single stranded DNA, reduces cellular proliferation and sensitizes cells to genotoxic stress
Veslemoy Rolseth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
DDB2 Suppresses Epithelial-to-Mesenchymal Transition in Colon Cancer
Nilotpal Roy et al.
CANCER RESEARCH (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Human NEIL3 is mainly a monofunctional DNA glycosylase removing spiroimindiohydantoin and guanidinohydantoin
Silje Z. Krokeide et al.
DNA REPAIR (2013)
The molecular biology of WHO Grade II gliomas
Nicholas F. Marko et al.
NEUROSURGICAL FOCUS (2013)
Modulation of HJURP (Holliday Junction-Recognizing Protein) Levels Is Correlated with Glioblastoma Cells Survival
Valeria Valente et al.
PLOS ONE (2013)
Release from quiescence stimulates the expression of human NEIL3 under the control of the Ras dependent ERK-MAP kinase pathway
Christine Gran Neurauter et al.
DNA REPAIR (2012)
Exo1 plays a major role in DNA end resection in humans and influences double-strand break repair and damage signaling decisions
Nozomi Tomimatsu et al.
DNA REPAIR (2012)
MGMT Gene Promoter Methylation as a Potent Prognostic Factor in Glioblastoma Treated With Temozolomide-Based Chemoradiotherapy: A Single-Institution Study
Young Suk Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Targeted Tissue Proteomic Analysis of Human Astrocytomas
Xueping Fang et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Thresholds of replication stress signaling in cancer development and treatment
Jiri Bartek et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China
Wei Yan et al.
PLOS ONE (2012)
On the origin of glioma
Yiwen Jiang et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2012)
A 4-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas
Marie de Tayrac et al.
CLINICAL CANCER RESEARCH (2011)
End-processing during non-homologous end-joining: a role for exonuclease 1
Karim Bahmed et al.
NUCLEIC ACIDS RESEARCH (2011)
Overview of Base Excision Repair Biochemistry
Yun-Jeong Kim et al.
Current Molecular Pharmacology (2011)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas
J. Bartkova et al.
ONCOGENE (2010)
Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR
Valeria Valente et al.
BMC MOLECULAR BIOLOGY (2009)
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
Elaine M. Dunleavy et al.
CELL (2009)
Centromere-Specific Assembly of CENP-A Nucleosomes Is Mediated by HJURP
Daniel R. Foltz et al.
CELL (2009)
Human Nei-like protein NEIL3 has AP lyase activity specific for single-stranded DNA and confers oxidative stress resistance in Escherichia coli mutant
Masashi Takao et al.
GENES TO CELLS (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21(Waf1/Cip1)
Tanya Stoyanova et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Activation of holliday junction-recognizing protein involved in the chromosomal stability and immortality of cancer cells
Tatsuya Kato et al.
CANCER RESEARCH (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
DDB1-DDB2 (Xeroderma Pigmentosum Group E) Protein Complex Recognizes a Cyclobutane Pyrimidine Dimer,Mismatches, Apurinic/Apyrimidinic Sites, and Compound Lesions in DNA
BO Wittschieben et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma
JM Nigro et al.
CANCER RESEARCH (2005)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
M Lacroix et al.
JOURNAL OF NEUROSURGERY (2001)
Malignant glioma: genetics and biology of a grave matter
EA Maher et al.
GENES & DEVELOPMENT (2001)
Share Paper
